Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Maui Land & Pineapple Co
MLP
$355M
| $170K | ﹤0.01% |
17,113
-870
| -5% | -$8.88K |
|
3577
PUT
Ciena
CIEN
$52.7B
| $169K | ﹤0.01% |
2,200
| – | – |
|
3578
Comp X International
CIX
$350M
| $169K | ﹤0.01% |
7,528
+1,292
| +21% | +$28.5K |
|
3579
Wave Life Sciences
WVE
$1.13B
| $169K | ﹤0.01% |
53,731
+38,114
| +244% | +$158K |
|
3580
TherapeuticsMD
TXMD
$23.5M
| $168K | ﹤0.01% |
9,465
+6,225
| +192% | +$187K |
|
3581
Alico
ALCO
$283M
| $166K | ﹤0.01% |
4,487
+2,985
| +199% | +$107K |
|
3582
Hurco Companies Inc
HURC
$137M
| $166K | ﹤0.01% |
5,577
-852
| -13% | -$27.2K |
|
3583
ADMA Biologics
ADMA
$2.01B
| $165K | ﹤0.01% |
117,238
-11,714
| -9% | -$15.4K |
|
|
EXTN
3584
DELISTED
Exterran Corporation
EXTN
| $164K | ﹤0.01% |
55,000
-43,232
| -44% | -$171K |
|
3585
PUT
Tenet Healthcare
THC
$20.3B
| $163K | ﹤0.01% |
2,000
| – | – |
|
3586
CALL
Macy's
M
$6.56B
| $160K | ﹤0.01% |
6,100
+6,000
| +6,000% | +$164K |
|
|
IMDX
3587
Insight Molecular Diagnostics
IMDX
$149M
| $158K | ﹤0.01% |
3,652
+2,422
| +197% | +$139K |
|
3588
First Trust Cloud Computing ETF
SKYY
$2.86B
| $156K | ﹤0.01% |
1,500
-33,053
| -96% | -$3.64M |
|
|
TCDA
3589
DELISTED
Tricida, Inc. Common Stock
TCDA
| $156K | ﹤0.01% |
16,277
-3,976
| -20% | -$25.6K |
|
3590
iShares US Aerospace & Defense ETF
ITA
$14.1B
| $155K | ﹤0.01% |
1,504
-373
| -20% | -$38.9K |
|
3591
Celcuity
CELC
$4.27B
| $154K | ﹤0.01% |
11,735
+7,784
| +197% | +$125K |
|
3592
PUT
Crocs
CROX
$6.14B
| $154K | ﹤0.01% |
1,200
| – | – |
|
3593
PUT
HSBC
HSBC
$367B
| $154K | ﹤0.01% |
5,100
| – | – |
|
|
GBL
3594
DELISTED
GAMCO Investors, Inc.
GBL
| $154K | ﹤0.01% |
6,170
+4,043
| +190% | +$104K |
|
3595
PUT
Alnylam Pharmaceuticals
ALNY
$27.5B
| $153K | ﹤0.01% |
+900
| New | +$167K |
|
|
XOMA
3596
DELISTED
Xoma
XOMA
| $152K | ﹤0.01% |
7,310
+4,847
| +197% | +$113K |
|
3597
PUT
MPLX
MPLX
$58.5B
| $151K | ﹤0.01% |
5,100
| – | – |
|
3598
USA Compression Partners
USAC
$3.79B
| $151K | ﹤0.01% |
8,654
-347
| -4% | -$5.54K |
|
3599
PUT
Pacific Biosciences
PACB
$460M
| $149K | ﹤0.01% |
+7,300
| New | +$176K |
|
3600
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.2B
| $149K | ﹤0.01% |
530
-139
| -21% | -$39.9K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.